ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74

Clinical trial NCT06714513 · RECRUITING

Trial details

NCT number: NCT06714513
Sponsor: Quratis Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Tuberculosis, Pulmonary

Start date: 2025-05-09
Primary completion: 2026-12-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.